Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
NADPH oxidase 1 (Nox1) is an enzyme that catalyzes the production of superoxide, a reactive oxygen species, using electrons from NADPH. It plays a role in redox signaling, epithelial immunity, and cell growth. Nox1 is implicated in the pathogenesis of atherosclerosis, cancer, and other diseases. ML171 is a selective inhibitor of Nox1.
Selective inhibition of Nox1 activity by blocking ROS production.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on NADPH oxidase 1 (Nox1).